Company Filing History:
1 out of 111 
1 out of 2,342 
Years Active: 2023
Title: Innovations in Musculoskeletal Treatment: The Breakthrough Work of Katie J Trella
Introduction
Katie J Trella, based in Chicago, IL, has made notable contributions to the field of medical treatment for musculoskeletal disorders. With one patent to her name, her innovative approach aims to enhance patient outcomes through rigorous monitoring methods.
Latest Patents
Trella's patent titled "Therapeutic target for musculoskeletal inflammation" introduces a method for monitoring treatment in patients with musculoskeletal disorders. This method involves measuring the expression levels of two specific biomarkers at a treatment site before and after the initiation of treatment. By comparing these levels, Trella's invention allows for the adjustment of treatment plans based on the patient's response. Additionally, her method includes a procedure for removing an aggrecan-hyaluronan matrix from the treatment site, which further improves the analysis and treatment of musculoskeletal conditions.
Career Highlights
Katie Trella's professional journey has been marked by significant contributions to research and clinical practice. She has worked at esteemed institutions such as Rush University Medical Center and the University of Illinois, where she has honed her expertise in musculoskeletal research and patient care.
Collaborations
Throughout her career, Trella has collaborated with notable colleagues, including Anna Plaas and Vincent Wang. Their joint efforts in research have contributed to advancements in understanding musculoskeletal diseases and developing innovative treatment methodologies.
Conclusion
Katie J Trella's innovative work in monitoring treatment for musculoskeletal disorders exemplifies the importance of research in enhancing medical interventions. Her patent not only reflects her dedication to improving patient care but also highlights the collaborative spirit within the medical and research communities. As advancements in this field continue, Trella's contributions stand out as a beacon of hope for patients suffering from musculoskeletal conditions.